Monopar Therapeutics
MNPR
MNPR
6 hedge funds and large institutions have $106K invested in Monopar Therapeutics in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 5 reducing their positions, and 7 closing their positions.
Holders
6
Holders Change
-6
Holders Change %
-50%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
5
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Geode Capital Management
Boston,
Massachusetts
|
$94.8K |
2 |
2
UBS Group
Zurich,
Switzerland
|
$3.45K |
Top Sellers
1 |
1
Millennium Management
New York
|
$0 |
2 |
TSS
2
Two Sigma Securities
New York
|
$0 |
3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$0 |
4 |
GL
4
Gerber LLC
Columbus,
Ohio
|
$0 |
5 |
VF
5
Virtu Financial
New York
|
$0 |